✦ LIBER ✦

Treatment of polycythemia vera with hydroxyurea

✍ Scribed by Rivka Sharon; Ilana Tatarsky; Yehudith Ben-Arieh

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 270 KB
Volume: 57
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860215)57:4<718::aid-cncr2820570406>3.0.co;2-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of polycythemia vera with hydr

Treatment of polycythemia vera with hydroxyurea

✍ Paul B. Donovan; Manuel E. Kaplan; Judith D. Goldberg; Ilana Tatarsky; Yves Naje 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 1 views

Pruritus secondary to hydroxyurea therap

Pruritus secondary to hydroxyurea therapy in a woman with polycythemia vera

✍ Evan Vosburgh 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Secondary treatment of polycythemia rubr

Secondary treatment of polycythemia rubra vera with 6-thioguanine

✍ Dr. D. W. Milligan; S. L. Thein; B. E. Roberts 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 1 views

6-thioguanine, an antimetabolite not potentiated by allopurinol, has been used in the treatment of 29 patients with polycythemia Vera. All but two of the patients had been treated previously by venesection and/or radioactive phosphorus (32p) and/or alkylating agents. The usual dose was 40-160 mg dai

Acute myeloid leukemia evolving from pol

Acute myeloid leukemia evolving from polycythemia vera in a patient treated with hydroxyurea

✍ Pulik, Marc; Lionnet, François; Genet, Philippe; Petitdidier, Charlotte; Jary, L 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

Leukemogenic risk of hydroxyurea therapy

Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

✍ Nand, Sucha; Stock, Wendy; Godwin, John; Fisher, Susan Gross 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 2 views

In polycythemia Vera (PV), treatment with chlorambucil and radioactive phosphorus (p32) increases the risk of leukemic transformation from 1% to 13-14%. This risk has been estimated to be 1-5.9% with hydroxyurea (HU) therapy. When compared with historical controls, the risk with use of HU does not a

POEMS syndrome associated with polycythe

POEMS syndrome associated with polycythemia vera

✍ William Schulz; Donald Domenico; Sucha Nand 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 2 views